Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-14T15:15:35.801Z Has data issue: false hasContentIssue false

Sexual dysfunction and the Mediterranean diet

Published online by Cambridge University Press:  01 December 2006

Dario Giugliano*
Affiliation:
Division of Metabolic Diseases, University of Naples SUN, Naples, Italy Center of Excellence for Cardiovascular Diseases, University of Naples SUN, Naples, Italy
Francesco Giugliano
Affiliation:
Division of Urology, University of Naples SUN, Naples, Italy
Katherine Esposito
Affiliation:
Division of Metabolic Diseases, University of Naples SUN, Naples, Italy Center of Excellence for Cardiovascular Diseases, University of Naples SUN, Naples, Italy
*
*Corresponding author: Email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Objectives

To discuss present knowledge about the relation between sexual dysfunction, metabolic factors and the Mediterranean-style diet.

Design

Review of the literature and personal perspectives.

Setting and results

Sexual problems appear to be widespread in society, influenced by both health-related and psychosocial factors, and are associated with impaired quality of life. Epidemiological studies suggest that modifiable health behaviours, including physical activity and leanness, are associated with a reduced risk for erectile dysfunction (ED) among men. Data from other surveys also indicate a higher prevalence of impotence in obese men. Obesity and the metabolic syndrome may be a risk factor for ED. The high prevalence of ED in patients with cardiovascular risk factors suggests that abnormalities of the vasodilator system of penile arteries play an important role in the pathophysiology of ED. We have shown that one-third of obese men with ED can regain their sexual activity after 2 years of adopting health behaviours, including a Mediterranean-style diet associated with regular exercise.

Conclusions

Western societies actually spend a huge part of their health care costs on chronic disease treatment and interventions for risk factors. The adoption of healthy lifestyles can reduce the prevalence of obesity and the metabolic syndrome, and hopefully the burden of sexual dysfunction.

Type
Research Paper
Copyright
Copyright © The Authors 2006

Erectile dysfunction (ED) is one of the most common chronic disorders affecting more than 100 million men worldwide. Thirty million men in the USA may have EDReference Laumann, Paik and Rosen1. Sexual problems appear to be widespread in society, influenced by both health-related and psychosocial factors, and are associated with impaired quality of life. Although many treatment options are available, none of them offers a complete response in all patients. Thus, as with many other medical diseases, prevention may be the most effective approach to alleviating the consequences of sexual dysfunctions. At a time in which obesity and the metabolic syndrome have become a public health crisis, modification of behavioural risk factors is strongly suggested to halt the progression of the epidemic and may also be a safe strategy for the ongoing increased sexual problems in population.

According to a recent CDC report, 64% of Americans (more than 127 000 000) are overweight: out of these, 30% are obese (60 000 000) and 4% are significantly obese2. An estimated 325 000 deaths and between 4.3 and 5.7% of direct health costs (approximately 39–52 billion dollars) are attributed to obesity annually. The worldwide prevalence is increasing at such a rapid pace that a WHO consultation on obesity designated obesity as the major unmet public health problem worldwide3. The metabolic syndrome (also referred to as syndrome X or insulin resistance syndrome) has emerged as an important cluster of risk factors for atherosclerotic disease. Common features are central (abdominal) obesity, insulin resistance, hypertension and dyslipidaemia (high triglycerides, low high-density lipoprotein cholesterol and small atherogenic low-density lipoprotein particles). Patients with the metabolic syndrome are at increased risk for diabetes and cardiovascular events. The ATP-III guideline4 also suggests a working definition of the metabolic syndrome that includes the presence of at least three of the following characteristics: abdominal obesity, elevated triglycerides, reduced levels of HDL cholesterol, high blood pressure and high fasting glucose. In particular, the cut-off values are the following: waist circumference >102 cm in men and >88 cm in women, triglycerides >150 mg dl− 1, HDL cholesterol < 40 mg dl− 1 in men and < 50 mg dl− 1 in women, blood pressure >130/85 mmHg and fasting glucose >110 mg dl− 1. Applying these criteria to the database of the Third National Health and Nutrition Examination Survey (NHANES III), it has been estimated that one out of four adults living in the USA merits the diagnosisReference Ford, Giles and Dietz5.

Epidemiological studies suggest that modifiable health behaviours, including physical activity and leanness, are associated with a reduced risk for sexual dysfunction. In the Health Professionals Follow-up StudyReference Bacon, Mittleman, Kawachi, Giovannucci, Glasser and Rimm6, several modifiable lifestyle factors, including physical activity and leanness, were associated with the maintenance of good erectile function. For instance, men with a Body Mass Index (BMI, calculated as weight in kilograms divided by the square of height in meters) higher than 28.7 are likely to carry a 30% higher risk for ED than those with a normal BMI (25 or lower). Data from other surveys also indicate a higher prevalence of impotence in obese menReference Pinnock, Stapleton and Marshall7, Reference Chung, Sohn and Park8.

Strong epidemiological evidence links the subsequent risk of ED to the presence of well-recognised risk factors for coronary heart disease, such as smoking, diabetes, hypertension and dyslipidaemiaReference Feldman, Johannes, Derby, Kleinman, Mohr and Araujo9Reference Seftel, Sun and Swindle11. As four of the five components of the metabolic syndrome are risk factors for ED and are also characterised by abnormal endothelial functionReference Celermajer, Sorensen, Bull, Robinson and Deanfield12, we postulated an association between the ED and the metabolic syndrome and tested the hypothesis that ED was more prevalent in men with the metabolic syndromeReference Esposito, Giugliano, Martedì, Feola, Marfella and D'Armiento13. When compared with age- and weight-matched control subjects (n = 50), patients with the metabolic syndrome (n = 100) had increased prevalence of ED (26.7 vs. 13%, P = 0.03); moreover, there was an increase in ED prevalence (IIEF < 21) as the number of components of the metabolic syndrome increased, suggesting that the cumulative burden of cardiovascular risk may be central to the pathogenesis of ED.

Obesity is an independent risk factor for cardiovascular diseaseReference Kopelman14, and is associated with elevated levels of several proinflammatory cytokines, as well as the sensitive marker of inflammation C-reactive protein (CRP). Markers of low-grade inflammation are positively associated with endothelial dysfunction in human obesityReference Ziccardi, Nappo, Giugliano, Esposito, Marfella and Cioffi15. We evaluated associations between erectile function, endothelial function and markers of systemic vascular inflammation in 80 obese men, aged 35–55 years, divided into two equal groups according to the presence/absence of EDReference Giugliano, Esposito, Di Palo, Ciotola, Giugliano and Marfella16. When compared with non-obese age-matched men (n = 50, BMI = 24 ± 1), obese men (all) had impaired indices of endothelial function and higher circulating concentrations of the proinflammatory cytokines interleukin-6, interleukin-8, interleukin-18 as well as CRP. Endothelial function showed a greater impairment in impotent obese men as compared with potent obese men, while circulating CRP levels were significantly higher in obese men with ED. The association we found between IIEF score and indices of endothelial dysfunction supports the presence of a possible common vascular pathway underlying both conditions in obese men. A defective nitric oxide activity, linked to reduced nitric oxide availability, could provide a unifying explanation for this association. In particular, in isolated corpus cavernosum strips from patients with ED, both neurogenic and endothelium-dependent relaxation is impairedReference Saenz de Tejada, Goldstein, Azadzoi, Krane and Cohen17.

Obesity and the metabolic syndrome are states of chronic oxidative stress and inflammationReference Esposito and Giugliano18 which may increase free radical formation that could quench and deactivate nitric oxide, reducing its availability for target cells. Obese men, who are successful in changing their lifestyle experience reduced oxidative stress associated with improved NO availabilityReference Roberts, Vaziri and Barnard19. Additionally, reduced CRP levels, due to sustained lifestyle changes, may contribute to amelioration of erectile function, as increased CRP levels correlate significantly with reduced NO availability and increasing severity of penile vascular disease as measured by penile DopplerReference Billups, Kaiser, Kelly, Wetterling, Tsai and Hanson20.

Erectile and endothelial dysfunctions may have some shared pathwaysReference Sullivan, Thompson, Dashwood, Khan, Jeremy and Morgan21, through a defect in nitric oxide activity which may be inhibited through age-, disease- and behaviour-related pathways. Intervention on modifiable health behaviours, especially reducing body weight and increasing physical activity, may in theory be a safe strategy to reduce the risk of both erectile and endothelial dysfunctions. We hypothesised that lifestyle changes aimed at reducing body weight and increasing physical activity would induce amelioration of erectile and endothelial functions in obese men. We conducted a randomised controlled trial involving 110 obese men with EDReference Esposito, Giugliano, Di Palo, Giugliano, Marfella and D'Andrea22. Men assigned to the intervention group were entered in an intensive weight loss programme, involving personalised dietary counselling and exercise advice and regular meetings with a nutritionist and personal trainer. The recommended composition of the dietary regimen was the following: carbohydrates 50–60%, proteins 15–20%, total fat < 30%, saturated fat < 10%, monounsaturated fat 10–15%, polyunsaturated fat 5–8%, fibre 18 g per 1000 kcal. The dietary advice was tailored to each man on the basis of food records collected on three non-consecutive days, which had to be done the week before the meeting with the nutritionist. Men in the control group were given general oral and written information about healthy food choices and exercise at baseline and at subsequent bimonthly visits, but no specific individualised programmes were offered to them. After 2 years, men randomised to the intervention had lost significantly more weight, increased their physical activity, experienced favourable changes in physiologic measures of endothelial dysfunction and had significant improvement in their ED score when compared with men in the control group. Moreover, patients on the intervention diet consumed a greater percentage of calories from complex carbohydrates, protein and monounsaturated fat; had a greater intake of fibre; had a lower ratio of ω-6 to ω-3 fatty acids; and lower energy, saturated fat and cholesterol than had controls. This study provided evidence that sustained lifestyle changes can partially ameliorate erectile function in obese men. In the Massachusetts Male Aging Study, Derby et al. Reference Derby, Mohr, Goldstein, Feldman, Johannes and McKinlay23 found that men who were overweight at baseline were at an increased risk of developing ED regardless of whether they lost weight during the follow-up records. About one-third of obese men with ED regained their sexual activity after 2 years of adopting health behaviours, mainly regular exercise, Mediterranean-style diet and reducing weight. This may be in line with epidemiological evidence that physical activity was associated with a 30% lower risk of ED, while obesity was associated with a 30% higher risk of ED. Additionally, men in the intervention programme showed improvement in the number of surrogate traditional and novel cardiovascular risk factors, which were better than those seen in control men.

Obesity and the metabolic syndrome are highly prevalent in the USA population. Thus, a large group of people are at increased risk for developing diabetes and cardiovascular disease. Because endothelial dysfunction may play a role in the pathophysiology of both these conditions and ED, the high prevalence of ED in people with obesity or the metabolic syndrome is of potential concern. Recent resultsReference Esposito, Giugliano, De Sio, Carleo, Di Palo and D'Armiento24 show that dietary factors may be important in the development of ED and claims for the widespread application of current nutritional guidelines, which insists upon increasing consumption of vegetables, fruit, nuts and healthy fatsReference Eyre, Kahn and Robertson25, whose intake is less represented in ED patients.

Promotion of healthful lifestyles, including Mediterranean-style diets and exercise, for primary prevention among individuals at all ages yield great benefits and reduce the burden of chronic diseases, and hopefully the burden of sexual dysfunction.

References

1Laumann, EO, Paik, A, Rosen, RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281: 537–44.CrossRefGoogle ScholarPubMed
2National Center for Chronic Prevention and Health Promotion. Defining Overweight and Obesity, Available at:www.cdc.gov/nccdphp/dnpa/obesity/defining.htm . Accessed March 25, 2006.Google Scholar
3WHO. Obesity: Preventing and Managing the Global Epidemics. Geneva: World Health Organization, 1998.Google Scholar
4Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 2001; 285: 2486–97.CrossRefGoogle Scholar
5Ford, ES, Giles, WH, Dietz, WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356–9.CrossRefGoogle ScholarPubMed
6Bacon, CG, Mittleman, MA, Kawachi, I, Giovannucci, E, Glasser, DB, Rimm, EB. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Annals of Internal Medicine 2003; 139: 161–8.CrossRefGoogle ScholarPubMed
7Pinnock, CB, Stapleton, AM, Marshall, VR. Erectile dysfunction in the community: a prevalence study. The Medical Journal of Australia 1999; 171: 353–7.CrossRefGoogle ScholarPubMed
8Chung, WS, Sohn, JH, Park, YY. Is obesity an underlying factor in erectile dysfunction? European Urology 1999; 36: 6870.CrossRefGoogle ScholarPubMed
9Feldman, HA, Johannes, CB, Derby, CA, Kleinman, KP, Mohr, BA, Araujo, AB, et al. . Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Preventive Medicine 2000; 30: 328–38.CrossRefGoogle ScholarPubMed
10Fung, MM, Bettencourt, R, Barrett-Connor, H. Heart disease risk factors predict erectile dysfunction 25 years later. Journal of the American College of Cardiology 2004; 43: 1405–11.CrossRefGoogle ScholarPubMed
11Seftel, AD, Sun, P, Swindle, R. The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. The Journal of Urology 2004; 171: 2341–5.CrossRefGoogle ScholarPubMed
12Celermajer, DS, Sorensen, KE, Bull, C, Robinson, J, Deanfield, JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interactions. Journal of the American College of Cardiology 1994; 24: 1468–74.CrossRefGoogle Scholar
13Esposito, K, Giugliano, F, Martedì, E, Feola, G, Marfella, R, D'Armiento, M, et al. . High proportions of erectile dysfunction in men with the metabolic sindrome. Diabetes Care 2005; 28: 1201–3.CrossRefGoogle Scholar
14Kopelman, PG. Obesity as a medical problem. Nature 2000; 404: 635–43.CrossRefGoogle ScholarPubMed
15Ziccardi, P, Nappo, F, Giugliano, G, Esposito, K, Marfella, R, Cioffi, M, et al. . Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105: 804–9.CrossRefGoogle ScholarPubMed
16Giugliano, F, Esposito, K, Di Palo, C, Ciotola, M, Giugliano, G, Marfella, R, et al. . Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokines levels in obese men. Journal of Endocrinological Investigation 2004; 27: 665–9.CrossRefGoogle ScholarPubMed
17Saenz de Tejada, I, Goldstein, I, Azadzoi, K, Krane, RJ, Cohen, RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. The New England Journal of Medicine 1989; 320: 1025–30.CrossRefGoogle ScholarPubMed
18Esposito, K, Giugliano, D. The metabolic syndrome and inflammation: association or causation? Nutrition, Metabolism, and Cardiovascular Disease 2004; 14: 228–32.CrossRefGoogle ScholarPubMed
19Roberts, C, Vaziri, ND, Barnard, RJ. Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability. Circulation 2002; 106: 2530–2.CrossRefGoogle ScholarPubMed
20Billups, KL, Kaiser, DR, Kelly, AS, Wetterling, RA, Tsai, MY, Hanson, M, et al. . Relation of C-reactive protein and other cardiovascular risk factors to penile vascular disease in men with erectile dysfunction. International Journal of Impotence Research 2003; 15: 231–6.Google ScholarPubMed
21Sullivan, ME, Thompson, CS, Dashwood, MR, Khan, MA, Jeremy, JY, Morgan, RJ, et al. . Nitric oxide and penile erections: is erectile dysfunction another manifestation of vascular disease? Cardiovascular Research 1999; 43: 658–65.CrossRefGoogle ScholarPubMed
22Esposito, K, Giugliano, F, Di Palo, C, Giugliano, G, Marfella, R, D'Andrea, F, et al. . Effect of lifestyle changes on erectile dysfunction in obese men: a randomized trial. JAMA 2004; 291: 2978–84.CrossRefGoogle Scholar
23Derby, CA, Mohr, BA, Goldstein, I, Feldman, HA, Johannes, CB, McKinlay, JB. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 2000; 56: 302–6.CrossRefGoogle ScholarPubMed
24Esposito, K, Giugliano, F, De Sio, M, Carleo, D, Di Palo, C, D'Armiento, M, et al. . Dietary factors in erectile dysfunction. International Journal of Impotence Research 2006; 18: 370–4.CrossRefGoogle ScholarPubMed
25Eyre, H, Kahn, R, Robertson, RM. Preventing cancer, cardiovascular disease and diabetes. Circulation 2004; 109: 244–55.CrossRefGoogle Scholar